BIOLOGICAL ROLE
Cellular pathways
Cellular metabolism and NAD-related pathways.
AEVIA / THE NAD+ COLLECTION
Explore the science. Discover the formats.
Ordering is not open. Each format retains its own product and supply checks.


01 / UNDERSTAND NAD+
NAD+ is a coenzyme, not a peptide. It participates in cellular redox chemistry.
Reviewed research sources ↓02 / EVIDENCE, IN CONTEXT
BIOLOGICAL ROLE
Cellular metabolism and NAD-related pathways.
RESEARCH CONTEXT
A small human pilot examined plasma and urine metabolites during an intravenous infusion.
Evidence context: human metabolism pilot.
This metabolic study does not establish anti-ageing, energy or cognitive benefits from AEVIA vials or pens. Precursor supplement studies are not interchangeable with NAD+ injections.
Read the selected references ↓Research about a compound is separate from the specification, safety and permitted supply of an AEVIA product.
03 / EXPLORE THE FORMATS
Explore each presentation and its own product information. No equivalence of dose, absorption or effect is implied.

GLASS VIAL
Shown: NAD+ · 500 mg artwork variant. Printed artwork quantities do not confirm filling specifications or an individual dose.
Price to confirm
View vial details →
DISTRIBUTOR CHANNEL
1,000 mg total per non-refillable pen, as confirmed by the owner. Total content is not an individual dose.
Distributor presentation. No direct consumer checkout.
View pen details →NEW FORMAT / IN DEVELOPMENT
A planned presentation. No finished product or packaging is shown.
Not available for purchase.
Development status →NEW FORMAT / IN DEVELOPMENT
A planned presentation. Formula, strength, pack contents, directions and availability have not been confirmed.
No finished product or packaging is presented here. Ordering is not open.
05 / YOUR QUESTIONS
No. Biochemical roles and studies of other formulations or routes do not establish benefits, safety or instructions for these AEVIA presentations.
Ordering is not open. The pen is a distributor-channel presentation. Product, specification, market and supply-permission checks remain in place for each format.
No. The owner-confirmed 1,000 mg is the total content per pen. It does not establish volume, concentration, dose increments or application instructions, and must not be transferred to the vial.
Only the planned format. Formula, strength, pack contents, directions and availability remain unconfirmed. There are no preorders.
The digital guide provides product information. The batch lookup checks a reference against the existing registry. A matched record does not establish the physical contents or permission for administration.
Open the digital pen guide →06 / FURTHER INFORMATION
Scientific references inform the research context above. They do not certify an AEVIA formulation or batch.